InsiderTrades

Form 4 for SRPT Sarepta Therapeutics, Inc.

Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-06 · accession 0000950170-25-036694 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-10 2025-03-07 SRPT Rodino-Klapac Louise CSO, Head of R, D F - Tax $103.70 -8,504 82.3K -9% -$881.9K
D 2025-03-10 2025-03-06 SRPT Rodino-Klapac Louise CSO, Head of R, D M - OptEx — +17.5K 82.8K +27% —
D 2025-03-10 2025-03-06 SRPT Rodino-Klapac Louise CSO, Head of R, D M - OptEx $0.00 -17.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-07 F D 7,990 $103.70 74,318 D — — (F3) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023.
2 Common Common Stock 2025-03-06 M A 17,500 — 82,822 D — — (F1) Represents the number of shares vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU.
3 Common Common Stock 2025-03-07 F D 514 $103.70 82,308 D — — (F2) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.
4 Derivative Performance Stock Units 2025-03-06 M D 17,500 $0.00 0 D — · — to — 17,500 Common Stock (F1) Represents the number of shares vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU.